BB BIOTECH Company Description
BB BIOTECH is banking on genetics. The investment firm funds biotechnology companies across the globe. BB BIOTECH's portfolio includes large stakes in half a dozen companies such as Actelion and Biogen Idec; the company also holds smaller shares in about 15 others (including Genentech. The firm usually makes only limited investments (not taking more than a 10% stake) in non-public companies. When considering an investment, the firm looks for key development markers. BB BIOTECH prefers to take stakes in companies that are within two years of bringing a product to market.
View the Comprehensive Company Description for BB BIOTECH
The Company Description provides a historical perspective of BB BIOTECH's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of BB BIOTECH's evolution in the marketplace.
